Global Fund HIV Project

The HIV Unit of Association for Reproductive and Family Health (ARFH) implemented the Global Fund New Funding Model 2 titled Optimizing HIV Investment for Impact between 1st July, 2019 to 31st December, 2020. ARFH worked as Sub-Recipient to fhi360 to implement the project in 11 State- Abia, Bayelsa, Benue, Delta, Edo, Enugu, Imo, Niger, Ogun Oyo and Osun spread across 63 Local Government Areas and with linkage to over 90 GF supported Health Facilities.

ARFH Awarded A1 rating by FHI360 as Sub-recipient under the Global Fund HIV Project

PHOTOSPEAK: ARFH Awarded A1 rating by FHI360 as Sub-recipient under the Global Fund HIV Project The HIV team of ARFH received an award from FHI360, the Principal Recipient of the Global Fund Investing for Impact Against HIV and TB Project for the successful implementation of her work on community HIV testing services as a Sub-recipient […]

ARFH Rolls Out Mobile Testing Tents to Increase Access to HIV Testing Services

As part of our strategies to enhance our delivery of community HIV counselling testing services, we recently procured and distributed HIV mobile testing tents to community testers in Akwa-Ibom, Imo, Kaduna, Oyo and Rivers state. The motivation behind the mobile testing tents is guided by our commitment to deliver HIV testing services as specified by […]


Today is International Day of Families, which is marked every year on May 15. The focus of this year is on issues relating to family with the theme “Families and inclusive societies.” This year’s commemoration draws attention to the role of families and family policies in advancing Sustainable Development Goal 16 in terms of Promoting […]

Nigeria launches new paediatric anti-TB medication for Tuberculosis treatment

Nigeria’s Minister of Health, Professor Isaac Adewole during a ministerial press briefing in commemoration of World Tuberculosis Day on Friday 23rd of March, launched a new paediatric anti-TB formulations for treatment of drug susceptible TB in children. In his speech, he explained that the new drug is dispersible and flavored, and meets the WHO optimal […]